A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours (Q33370792)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours |
scientific article |
Statements
1 reference
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours (English)
1 reference
H Dumez
1 reference
A Awada
1 reference
M Piccart
1 reference
S Assadourian
1 reference
D Semiond
1 reference
G Guetens
1 reference
G de Boeck
1 reference
R A A Maes
1 reference
E A de Bruijn
1 reference
A van Oosterom
1 reference
6 April 2006
1 reference
1 reference
17
1 reference
1158-1165
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference